menu
    • menu

    Company profile for Novo Integrated Sciences

    NEW Drugs in Dev: 1
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Novo Integrated Sciences (NASDAQ: NVOS) owns Canadian and U.S. subsidiaries which deliver, or intend to deliver, multidisciplinary primary health care related services and products through the integration of medical technology, advanced therapeutics and rehabilitative science. Currently, the Company’s revenue is generated solely through its wholly owned Canadian subsidiary, Novo Healthnet Limited (“NHL”). NHL’s team of...
    Novo Integrated Sciences (NASDAQ: NVOS) owns Canadian and U.S. subsidiaries which deliver, or intend to deliver, multidisciplinary primary health care related services and products through the integration of medical technology, advanced therapeutics and rehabilitative science. Currently, the Company’s revenue is generated solely through its wholly owned Canadian subsidiary, Novo Healthnet Limited (“NHL”). NHL’s team of multidisciplinary primary health care clinicians and practitioners provide assessment, diagnosis, treatment, pain management, rehabilitation.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Novo Integrated SciencesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    11120 NE 2nd Street, Suite 100 Bellevue, Washington 98004
    Telephone
    Telephone
    (888) 512-1195
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.novointegrated.com/en
    Linkedin
    Linkedin
    https://www.linkedin.com/company/novo-integrated-sciences-inc/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    RDD

    RDD

    Not Confirmed

    envelop Contact Supplier

    RDD

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Novo Integrated Sciences Q2 FY2024 Results
    Novo Integrated Sciences Q2 FY2024 Results

    15 Apr 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240415120487/en

    BUSINESSWIRE
    15 Apr 2024
    Share Share
    Novo Integrated Sciences Provides Update on Certain Current Events
    Novo Integrated Sciences Provides Update on Certain Current Events

    06 Oct 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231006132923/en

    BUSINESSWIRE
    06 Oct 2023
    Share Share
    Novo Integrated Sciences’ IoNovo Iodine Granted Registration Number
    Novo Integrated Sciences’ IoNovo Iodine Granted Registration Number

    22 Aug 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230822371358/en

    BUSINESSWIRE
    22 Aug 2023
    Share Share
    Novo Integrated Sciences Signs Agreements for an Unsecured, Non-dilutive Debt
    Novo Integrated Sciences Signs Agreements for an Unsecured, Non-dilutive Debt

    27 Apr 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230427005373/en

    BUSINESSWIRE
    27 Apr 2023
    Share Share
    Novo Integrated Sciences’ Subsidiary, Signs Agreement with Sarfez Pharma
    Novo Integrated Sciences’ Subsidiary, Signs Agreement with Sarfez Pharma

    30 Nov 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20221130005326/en

    BUSINESSWIRE
    30 Nov 2022
    Share Share
    Clinical Consultants, Signs Consulting Services Agreement with Softhread
    Clinical Consultants, Signs Consulting Services Agreement with Softhread

    12 Oct 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20221012005316/en

    BUSINESSWIRE
    12 Oct 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search